{"gao_id": "GAO-18-585T", "published": "2018-05-29T12:00:00Z", "released": "2018-05-29T08:00:00Z", "summary": "What can Medicare do to help address the nation's opioid crisis? We've previously found problems such as \"doctor shopping\" and questionable prescribing practices in Medicare's prescription drug benefits. 14.4 million people were prescribed at least one opioid through Medicare in 2016. While many opioids prescribed addressed legitimate need, others may have been overprescribed. This testimony revisits our analysis of Medicare's efforts to reduce inappropriate opioid...", "title": "Prescription Opioids: Medicare Needs Better Information to Reduce the Risk of Harm to Beneficiaries", "topics": ["Pharmaceutical industry", "Patient care", "Substance abuse", "Prescription drugs", "Reporting requirements", "Mortality", "Health Care", "Medicare plans", "Internal controls", "Health care", "Compliance oversight", "Medicare beneficiaries", "Controlled substances", "Deaths", "Data collection", "Drugs", "Pharmacy", "Medicare", "Beneficiaries", "Monitoring"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-18-585t", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-18-585t-highlights.pdf"}, {"title": "Full Report (17 pages)", "url": "https://www.gao.gov/assets/gao-18-585t.pdf"}, {"title": "Accessible PDF (16 pages)", "url": "https://www.gao.gov/assets/700/692440.pdf"}]}